Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03769155
Title VX15/2503 With or Without Ipilimumab and/or Nivolumab in Patients With Resectable Stage IIIB-D Melanoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Emory University
Indications

melanoma

Therapies

Nivolumab + Pepinemab

Ipilimumab + Pepinemab

Pepinemab

Ipilimumab + Nivolumab + Pepinemab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Emory University Hospital/Winship Cancer Institute Recruiting Atlanta Georgia 30322 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field